FROM Steve Scherer
Mixed messages from America's new hard line on Syria Last week, President Trump stunned the world by striking Syria with 59 Tomahawk missiles in retaliation for Bashar al-Assad's use of chemical weapons against his own people. Since then, American diplomats have made contradictory statements in the aftermath of the attack. Was it a "one-off" or is regime change the goal? And why has President Trump retaliated against Syria's use of chemical weapons — but not conventional weapons, which are just as deadly? America's G-7 allies are meeting in Italy to find a consensus for dealing with Syria -- and with Russia — the next stop for America's Secretary of State. Is it too soon for the "political solution" all sides claim to prefer, or will force be used in attempting to remove the Assad regime from power?
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.